Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 309

1.

Real-world weight change among patients treated with glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas for type 2 diabetes and the influence of medication adherence.

Carls GS, Tan R, Zhu JY, Tuttle E, Yee J, Edelman SV, Polonsky WH.

Obes Sci Pract. 2017 Jul 20;3(3):342-351. doi: 10.1002/osp4.116. eCollection 2017 Sep.

3.

Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 Diabetes.

Carls GS, Tuttle E, Tan RD, Huynh J, Yee J, Edelman SV, Polonsky WH.

Diabetes Care. 2017 Nov;40(11):1469-1478. doi: 10.2337/dc16-2725. Epub 2017 Aug 11.

PMID:
28801475
4.

Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control.

Edelman SV, Polonsky WH.

Diabetes Care. 2017 Nov;40(11):1425-1432. doi: 10.2337/dc16-1974. Epub 2017 Aug 11.

PMID:
28801473
5.

Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia.

Dhere V, Edelman S, Waller EK, Langston A, Graiser M, Connolly EC, Switchenko JM, Esiashvili N, Khan MK.

Leuk Lymphoma. 2017 Aug 7:1-7. doi: 10.1080/10428194.2017.1361027. [Epub ahead of print]

PMID:
28782395
6.

The evolution of cognitive mechanisms in response to cultural innovations.

Lotem A, Halpern JY, Edelman S, Kolodny O.

Proc Natl Acad Sci U S A. 2017 Jul 24. pii: 201620742. doi: 10.1073/pnas.1620742114. [Epub ahead of print]

7.

Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.

Berard L, Bonnemaire M, Mical M, Edelman S.

Diabetes Obes Metab. 2017 Jul 18. doi: 10.1111/dom.13064. [Epub ahead of print]

PMID:
28719066
8.

Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014.

Carls G, Huynh J, Tuttle E, Yee J, Edelman SV.

Diabetes Ther. 2017 Aug;8(4):863-873. doi: 10.1007/s13300-017-0280-5. Epub 2017 Jun 23.

9.

Where Are We Now? A Clinicians' Guide to the Use of Follow-On Insulin for Patients with Diabetes.

Edelman SV, Hollander PA, Wright EE Jr.

Am J Med. 2017 May;130(5):614. doi: 10.1016/j.amjmed.2017.03.007.

PMID:
28431671
10.

Physician-patient communication at diagnosis of type 2 diabetes and its links to patient outcomes: New results from the global IntroDia® study.

Polonsky WH, Capehorn M, Belton A, Down S, Alzaid A, Gamerman V, Nagel F, Lee J, Edelman S.

Diabetes Res Clin Pract. 2017 May;127:265-274. doi: 10.1016/j.diabres.2017.03.016. Epub 2017 Mar 22.

PMID:
28407552
11.

Challenges faced by physicians when discussing the Type 2 diabetes diagnosis with patients: insights from a cross-national study (IntroDia® ).

Capehorn M, Polonsky WH, Edelman S, Belton A, Down S, Gamerman V, Nagel F, Lee J, Alzaid A.

Diabet Med. 2017 Aug;34(8):1100-1107. doi: 10.1111/dme.13357. Epub 2017 May 21.

PMID:
28370335
12.

Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic.

Hirsch JD, Bounthavong M, Arjmand A, Ha DR, Cadiz CL, Zimmerman A, Ourth H, Morreale AP, Edelman SV, Morello CM.

J Manag Care Spec Pharm. 2017 Mar;23(3):318-326. doi: 10.18553/jmcp.2017.23.3.318.

13.

Administration of Biosimilar Insulin Analogs: Role of Devices.

Heinemann L, Fritz I, Khatami H, Edelman SV.

Diabetes Technol Ther. 2017 Feb;19(2):79-84. doi: 10.1089/dia.2016.0263. Review.

PMID:
28118050
14.

Investigating Hypoglycemic Confidence in Type 1 and Type 2 Diabetes.

Polonsky WH, Fisher L, Hessler D, Edelman SV.

Diabetes Technol Ther. 2017 Feb;19(2):131-136. doi: 10.1089/dia.2016.0366. Epub 2016 Dec 20.

PMID:
27997217
15.

Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.

Jacobson TA, Edelman SV, Galipeau N, Shields AL, Mallya UG, Koren A, Davidson MH.

Patient. 2017 Jun;10(3):321-334. doi: 10.1007/s40271-016-0211-y.

16.

Mature Let-7 miRNAs fine tune expression of LIN28B in pluripotent human embryonic stem cells.

Rahkonen N, Stubb A, Malonzo M, Edelman S, Emani MR, Närvä E, Lähdesmäki H, Ruohola-Baker H, Lahesmaa R, Lund R.

Stem Cell Res. 2016 Nov;17(3):498-503. doi: 10.1016/j.scr.2016.09.025. Epub 2016 Sep 24.

17.

Regulation Catches Up to Reality.

Edelman SV.

J Diabetes Sci Technol. 2017 Jan;11(1):160-164. doi: 10.1177/1932296816667749. Epub 2016 Sep 25.

18.

The bottleneck may be the solution, not the problem.

Lotem A, Kolodny O, Halpern JY, Onnis L, Edelman S.

Behav Brain Sci. 2016 Jan;39:e83. doi: 10.1017/S0140525X15000886.

PMID:
27562516
19.

Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes.

Pettus J, Edelman SV.

J Diabetes Sci Technol. 2017 Jan;11(1):138-147. doi: 10.1177/1932296816663747. Epub 2016 Aug 20. Review.

20.

System, Subsystem, Hive: Boundary Problems in Computational Theories of Consciousness.

Fekete T, van Leeuwen C, Edelman S.

Front Psychol. 2016 Jul 27;7:1041. doi: 10.3389/fpsyg.2016.01041. eCollection 2016.

Supplemental Content

Loading ...
Support Center